199 related articles for article (PubMed ID: 21619704)
1. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma.
Mirabello L; Yu K; Berndt SI; Burdett L; Wang Z; Chowdhury S; Teshome K; Uzoka A; Hutchinson A; Grotmol T; Douglass C; Hayes RB; Hoover RN; Savage SA;
BMC Cancer; 2011 May; 11():209. PubMed ID: 21619704
[TBL] [Abstract][Full Text] [Related]
2. The effects of common variants in MDM2 and GNRH2 genes on the risk and survival of osteosarcoma in Han populations from Northwest China.
Feng W; Wang Z; Feng D; Zhu Y; Zhang K; Huang W
Sci Rep; 2020 Sep; 10(1):15939. PubMed ID: 32994424
[TBL] [Abstract][Full Text] [Related]
3. GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population.
Jiang C; Chen H; Shao L; Dong Y
Med Oncol; 2014 Jul; 31(7):50. PubMed ID: 24984297
[TBL] [Abstract][Full Text] [Related]
4. Germ-line genetic variation of TP53 in osteosarcoma.
Savage SA; Burdett L; Troisi R; Douglass C; Hoover RN; Chanock SJ;
Pediatr Blood Cancer; 2007 Jul; 49(1):28-33. PubMed ID: 17096406
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in miRNA processing genes and their role in osteosarcoma risk.
Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Martin-Guerrero I; Pombar-Gomez M; Zalacain-Diez M; Patiño-Garcia A; Lopez-Lopez E; Garcia-Orad A
Pediatr Blood Cancer; 2015 May; 62(5):766-9. PubMed ID: 25663449
[TBL] [Abstract][Full Text] [Related]
6. Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma.
Savage SA; Woodson K; Walk E; Modi W; Liao J; Douglass C; Hoover RN; Chanock SJ;
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1667-74. PubMed ID: 17684144
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation at chromosome 8q24 in osteosarcoma cases and controls.
Mirabello L; Berndt SI; Seratti GF; Burdett L; Yeager M; Chowdhury S; Teshome K; Uzoka A; Douglass C; Hayes RB; Hoover RN; Savage SA;
Carcinogenesis; 2010 Aug; 31(8):1400-4. PubMed ID: 20530236
[TBL] [Abstract][Full Text] [Related]
8. Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese.
He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
Endocr J; 2013; 60(11):1215-20. PubMed ID: 23933591
[TBL] [Abstract][Full Text] [Related]
9. Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.
Wang Z; Wen P; Luo X; Fang X; Wang Q; Ma F; Lv J
Tumour Biol; 2014 Apr; 35(4):3605-10. PubMed ID: 24310504
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.
Lu H; Zhu L; Lian L; Chen M; Shi D; Wang K
Tumour Biol; 2015 Jul; 36(7):5241-7. PubMed ID: 25663494
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
12. Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules.
Poos K; Smida J; Maugg D; Eckstein G; Baumhoer D; Nathrath M; Korsching E
PLoS One; 2015; 10(4):e0123082. PubMed ID: 25848766
[TBL] [Abstract][Full Text] [Related]
13. Effect of TIMP2/TIMP3 genes on the risk of osteosarcoma in Zhejiang population.
Wu Z; Chen H; Pan L; Yu W; Lou C; Chen J; He D
Medicine (Baltimore); 2021 Mar; 100(11):e24818. PubMed ID: 33725949
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
Ru JY; Cong Y; Kang WB; Yu L; Guo T; Zhao JN
Int J Clin Exp Pathol; 2015; 8(3):3198-203. PubMed ID: 26045840
[TBL] [Abstract][Full Text] [Related]
15. Association between H19 polymorphisms and osteosarcoma risk.
He TD; Xu D; Sui T; Zhu JK; Wei ZX; Wang YM
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3775-3780. PubMed ID: 28975992
[TBL] [Abstract][Full Text] [Related]
16. Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Yang J; Wang ZG; Cai HQ; Li YC; Xu YL
Asian Pac J Cancer Prev; 2013; 14(8):4595-8. PubMed ID: 24083708
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms of HER2 related to osteosarcoma susceptibility.
Xin DJ; Shen GD; Song J
Int J Clin Exp Pathol; 2015; 8(8):9494-9. PubMed ID: 26464710
[TBL] [Abstract][Full Text] [Related]
18. CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma.
Wang W; Song H; Liu J; Song B; Cao X
DNA Cell Biol; 2011 Nov; 30(11):925-9. PubMed ID: 21563968
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants associated with osteosarcoma risk: a systematic review and meta-analysis.
Hassanain O; Alaa M; Khalifa MK; Kamal N; Albagoury A; El Ghoneimy AM
Sci Rep; 2024 Feb; 14(1):3828. PubMed ID: 38360742
[TBL] [Abstract][Full Text] [Related]
20. Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population.
He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
Endocrine; 2014 Mar; 45(2):325-30. PubMed ID: 24078408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
